Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Walden

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Kidney International|June 16, 2005
Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patternsKasper Rossing, Harald Mischak, Hans-Henrik Parving, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 21, 2004
Proteomics: a novel tool to unravel the patho-physiology of uraemiaEva M Weissinger, Thorsten Kaiser, Natalie Meert, et al.
Analytical Biochemistry|May 4, 2005
In vitro degradation of the antimicrobial human peptide HEM-gamma 130-146 in plasma analyzed by a validated quantitative LC-MS/MS procedureHarald John, Kham Dieu Huynh, Christiane Hedtmann, et al.
Kidney International|May 11, 2005
Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathyMarion Haubitz, Stefan Wittke, Eva M Weissinger, et al.
Nature Medicine|March 22, 2006
Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysisStephane Decramer, Stefan Wittke, Harald Mischak, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipientsStefan Wittke, Marion Haubitz, Michael Walden, et al.
Clinical Science (London, England : 1979)|July 30, 2004
Proteomic analysis for the assessment of diabetic renal damage in humansHarald Mischak, Thorsten Kaiser, Michael Walden, et al.
The Lancet. Oncology|March 3, 2006
Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysisDan Theodorescu, Stefan Wittke, Mark M Ross, et al.
Electrophoresis|June 28, 2005
Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urineDan Theodorescu, Danilo Fliser, Stefan Wittke, et al.
Analytical Chemistry|November 16, 2005
Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal diseaseMichael J Chalmers, Colin Logan Mackay, Christopher L Hendrickson, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Kidney International|June 16, 2005
Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patternsKasper Rossing, Harald Mischak, Hans-Henrik Parving, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 21, 2004
Proteomics: a novel tool to unravel the patho-physiology of uraemiaEva M Weissinger, Thorsten Kaiser, Natalie Meert, et al.
Analytical Biochemistry|May 4, 2005
In vitro degradation of the antimicrobial human peptide HEM-gamma 130-146 in plasma analyzed by a validated quantitative LC-MS/MS procedureHarald John, Kham Dieu Huynh, Christiane Hedtmann, et al.
Kidney International|May 11, 2005
Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathyMarion Haubitz, Stefan Wittke, Eva M Weissinger, et al.
Nature Medicine|March 22, 2006
Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysisStephane Decramer, Stefan Wittke, Harald Mischak, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipientsStefan Wittke, Marion Haubitz, Michael Walden, et al.
Clinical Science (London, England : 1979)|July 30, 2004
Proteomic analysis for the assessment of diabetic renal damage in humansHarald Mischak, Thorsten Kaiser, Michael Walden, et al.
The Lancet. Oncology|March 3, 2006
Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysisDan Theodorescu, Stefan Wittke, Mark M Ross, et al.
Electrophoresis|June 28, 2005
Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urineDan Theodorescu, Danilo Fliser, Stefan Wittke, et al.
Analytical Chemistry|November 16, 2005
Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal diseaseMichael J Chalmers, Colin Logan Mackay, Christopher L Hendrickson, et al.
Pageof 3